MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Cancer Immunotherapy and Biomarkers
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,980 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,980 works in the cohort · of 4,299,418page 37 of 60

Labels cover 12 of 2,980 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,980 of 2,980 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Immunogenic Cell Death in Cancer
Juliette Humeau, Julie Le Naour, Guido Kroemer, Jonathan Pol
2023· book-chapter· en· Interdisciplinary cancer research· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affno abstractunlabeled
Body-mass index and metastatic melanoma outcomes
Hermann Nabi, Jason R. Guertin, Denis Talbot, Caroline Diorio
2018· letter· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
afffundunlabeled
Metastasis: A Bane of Breast Cancer Therapy
Chidalu A. Edechi, Nnamdi Ikeogu, Lucas E. L. Terceiro, Jude E. Uzonna, Yvonne Myal
2020· article· en· European Medical Journal· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Error in Table 2
Steven A. Narod, Vasily Giannakeas, Victoria Sopik
2020· erratum· en· JAMA Oncology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
afffundno abstractunlabeled
In Reply
Nancy N. Baxter
2007· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Abstract C027: A Phase I, dose finding study of BI 754111, an anti-LAG-3 antibody, in combination with BI 754091, an anti-PD-1 antibody, in patients with advanced solid tumors: preliminary results from the microsatellite stable (MSS) metastatic colorectal cancer (mCRC) cohort
Johanna C. Bendell, Susanna V. Ulahannan, Quincy S. Chu, Manish R. Patel, Ben George, Renee Landsberg +7 more
2019· article· en· Molecular Cancer Therapeutics· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
← previousnext →

How this was built: Screen · Findings · About